Search Ontology:
ChEBI
alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
- Term ID
- CHEBI:60948
- Synonyms
-
- (Gal)2 (Glc)1
- 4'-galactosyllactose
- 4-O-(4-O-alpha-D-galactopyranosyl-beta-D-galactopyranosyl)-D-glucopyranose
- alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
- alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-D-glucose
- alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
- Gal-alpha-1,4-Gal-beta-1,4-Glc
- Gal-alpha1,4Gal-beta1,4-Glc
- Galalpha1,4Gal-beta1,4Glc
- Galalpha1-4Gal-beta1-4Glc
- Galalpha1-4Gal-beta1-4Glc~OH
- Pk
- Definition
- A linear trisaccharide comprising D-glucose (at the reducing end) having an α-D-galactosyl-(1→4)-β-D-galactosyl moiety at the 4-position.
- References
-
- cas:80446-87-3
- glygen:G06000DZ
- glytoucan:G06000DZ
- kegg.glycan:G03416
- pubmed:12020649
- pubmed:16133831
- pubmed:17991151
- pubmed:2292729
- pubmed:2456994
- pubmed:9538266
- reaxys:5386141
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
Phenotype where environments contain alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
Phenotype modified by environments containing alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
Phenotype affecting alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
Human Disease Model